Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

Qurient Co., Ltd. · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
cervical-cancergastric-cancer
esophageal cancer, gastric cancer, hepatocellular cancer, cervical cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 895281
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.